Concomitantly, increased levels of IL‐22 as well as tryptophan metabolites (quinolinic acid) were measured in serum of patients, which indicated a high activity of tryptophan degradation in patients with active IBD. The gene discussed is IL22; the disease is inflammatory bowel disease.